FDA Approves Novartis’ Scemblix for Treatment of Chronic Myeloid Leukemia November 2, 2021 Auto Bot News 0 Novartis’ scemblix (asciminib) is designed to provide a single treatment option to patients struggling with chronic myeloid leukemia.
